CTLA4 and neoplasm: Contrary to our expectations, mild tumor regression was observed in the SiLN contralateral to the anti-CTLA4 injected SiLN but not the anti-CTLA4 injected SiLN (Fig. 4 B – C, Fig. S3 A).